BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7636236)

  • 1. Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells.
    Rowell JF; Ruff AL; Guarnieri FG; Staveley-O'Carroll K; Lin X; Tang J; August JT; Siliciano RF
    J Immunol; 1995 Aug; 155(4):1818-28. PubMed ID: 7636236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC.
    Rowell JF; Stanhope PE; Siliciano RF
    J Immunol; 1995 Jul; 155(1):473-88. PubMed ID: 7602119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments.
    Kang TH; Lee JH; Bae HC; Noh KH; Kim JH; Song CK; Shin BC; Hung CF; Wu TC; Park JS; Kim TW
    Immunol Lett; 2006 Aug; 106(2):126-34. PubMed ID: 16844231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II compartment, and enhanced neutralizing antibody response.
    Anwar A; Chandrasekaran A; Ng ML; Marques E; August JT
    Virology; 2005 Feb; 332(1):66-77. PubMed ID: 15661141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane.
    Chow A; Toomre D; Garrett W; Mellman I
    Nature; 2002 Aug; 418(6901):988-94. PubMed ID: 12198549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanosomal targeting sequences from gp100 are essential for MHC class II-restricted endogenous epitope presentation and mobilization to endosomal compartments.
    Lepage S; Lapointe R
    Cancer Res; 2006 Feb; 66(4):2423-32. PubMed ID: 16489049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC; Steele CR; Gu L; Song W; Pierce SK
    J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.
    Michalek MT; Benacerraf B; Rock KL
    J Immunol; 1992 Feb; 148(4):1016-24. PubMed ID: 1737924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.
    Li P; Gregg JL; Wang N; Zhou D; O'Donnell P; Blum JS; Crotzer VL
    Immunol Rev; 2005 Oct; 207():206-17. PubMed ID: 16181338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes.
    Siemasko K; Eisfelder BJ; Williamson E; Kabak S; Clark MR
    J Immunol; 1998 Jun; 160(11):5203-8. PubMed ID: 9605114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    Pinet V; Malnati MS; Long EO
    J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway.
    Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C
    Cell Biol Int; 1994 May; 18(5):315-20. PubMed ID: 8049676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endolyn is a mucin-like type I membrane protein targeted to lysosomes by its cytoplasmic tail.
    Ihrke G; Gray SR; Luzio JP
    Biochem J; 2000 Jan; 345 Pt 2(Pt 2):287-96. PubMed ID: 10620506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.
    Lekutis C; Shiver JW; Liu MA; Letvin NL
    J Immunol; 1997 May; 158(9):4471-7. PubMed ID: 9127013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes.
    Scardino A; Paroli M; De Petrillo G; Michel ML; Barnaba V
    Immunology; 1994 Jan; 81(1):167-70. PubMed ID: 7907575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells.
    Knolle PA; Germann T; Treichel U; Uhrig A; Schmitt E; Hegenbarth S; Lohse AW; Gerken G
    J Immunol; 1999 Feb; 162(3):1401-7. PubMed ID: 9973395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma mediates antigen trafficking to MHC class II-positive late endosomes of enterocytes.
    Büning J; Schmitz M; Repenning B; Ludwig D; Schmidt MA; Strobel S; Zimmer KP
    Eur J Immunol; 2005 Mar; 35(3):831-42. PubMed ID: 15688349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells.
    Kleijmeer MJ; Ossevoort MA; van Veen CJ; van Hellemond JJ; Neefjes JJ; Kast WM; Melief CJ; Geuze HJ
    J Immunol; 1995 Jun; 154(11):5715-24. PubMed ID: 7751623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.